Insider filing · JAZZ
Patricia Carr
SVP, Chief Accounting Officer
profile →
Jazz Pharmaceuticals plc
JAZZ · Healthcare · 46 filings in 24 months
ticker →
Patricia Carr sold $770K of Jazz Pharmaceuticals (JAZZ)
Executed Dec 5 2025, disclosed Dec 9 2025, 4 days later.
Value, as filed
$770K
4,500 sh × $171.20
Executed
Dec 5 2025
the trade date, as filed
Disclosed
Dec 9 2025
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
PCPatricia Carr (SVP, Chief Accounting Officer) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Jazz Pharmaceuticals plc (JAZZ). The largest single filing was $956K of JAZZ (5,250 sh × $182.07, as filed), executed Nov 18 2025.
The name
JAZZHealthcare · Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Patricia Carr in JAZZ
JAZZSALE
Jazz Pharmaceuticals plc
$235K1,287 sh × $182.94
Exec Mar 9
Filed Mar 9 · 5:30 PM ET JAZZSALE Jazz Pharmaceuticals plc $456K
2,370 sh across 2 lots
Exec Feb 26
Filed Mar 2 · 5:30 PM ET JAZZSALE Jazz Pharmaceuticals plc $956K
5,250 sh × $182.07
Exec Nov 18 2025
Filed Nov 20 2025 · 5:30 PM ET JAZZSALE Jazz Pharmaceuticals plc $157K
1,140 sh × $137.81
Exec Mar 10 2025
Filed Mar 11 2025 · 5:30 PM ET JAZZSALE Jazz Pharmaceuticals plc $761K
5,273 sh across 2 lots
Exec Feb 27 2025
Filed Mar 3 2025 · 5:30 PM ET